HANSA BIOPHARMA AB |
Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
| 33,58 SEK | -3,45% |
|
-7,54% | -14,34% |
| 20/12 | Redeye alza il fair value di Hansa Biopharma dopo i risultati positivi dello studio per la GBS | FW |
| 18/12 | Hansa Biopharma AB - Special Call |
Principali concorrenti
Aggiungi a un elenco 0 selezionato | Variaz. | Variaz. 5g. | Variazione 1 mese | Variazione 3 mesi | Variaz. 1 gen. | Variaz. 1 anno | Variaz. 3 anni | Variaz. 5 anni | Variaz. 10 anni | Capi. ($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3,45% | -7,54% | +14,30% | -18,06% | -14,34% | -0,53% | -58,69% | -52,03% | -6,72% | 210 Mln | ||
| -1,73% | +0,48% | +2,18% | +0,67% | +1,61% | +46,90% | -18,48% | +51,14% | +341,52% | 43,61 Mrd | ||
| +0,43% | +2,17% | +2,28% | -12,70% | +3,61% | -4,28% | -19,23% | +28,74% | +242,23% | 36,89 Mrd | ||
| -0,70% | +1,60% | +4,38% | -2,18% | -1,97% | -1,99% | +1,88% | +17,64% | +540,80% | 27,04 Mrd | ||
| -0,43% | +0,41% | +3,96% | -27,03% | +3,19% | -13,76% | -21,21% | +28,29% | +286,07% | 18,02 Mrd | ||
| +0,70% | +2,89% | +1,06% | +2,40% | +3,63% | +67,18% | +75,80% | +324,20% | +171,44% | 16,29 Mrd | ||
| -20,52% | -19,78% | -18,36% | -40,85% | -17,87% | -66,57% | -83,75% | +68,56% | - | 16,26 Mrd | ||
| +3,05% | +1,54% | -0,39% | +2,13% | +4,67% | +5,55% | -24,17% | +38,79% | +226,07% | 11,65 Mrd | ||
| +0,45% | +2,30% | +1,16% | -1,01% | +5,33% | +22,07% | +94,11% | +309,67% | - | 10,88 Mrd | ||
| +2,38% | +2,21% | +0,81% | +3,81% | +2,78% | -1,58% | -8,76% | +26,41% | +83,57% | 9,93 Mrd | ||
| +2,19% | +0,12% | -0,36% | -1,75% | +2,80% | -8,07% | -46,07% | +19,28% | +175,47% | 9,52 Mrd | ||
| +1,42% | -3,67% | -6,18% | -14,20% | -3,45% | +54,24% | +68,25% | - | - | 7,72 Mrd | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 6,07 Mrd | ||
| -13,34% | -20,40% | -20,87% | -36,03% | -3,90% | - | - | - | - | 5,91 Mrd | ||
| +10,66% | +8,77% | +4,51% | +9,86% | +11,66% | +20,95% | +28,33% | +28,75% | - | 5,55 Mrd | ||
| +1,20% | -6,41% | -23,72% | -21,20% | -9,08% | -0,92% | -58,44% | -28,54% | +392,99% | 5,39 Mrd | ||
| +0,99% | +0,12% | -16,92% | -12,98% | -5,02% | -9,53% | -59,32% | +9,87% | - | 5,35 Mrd | ||
| +3,75% | +1,22% | -5,72% | -10,65% | -1,27% | -32,36% | +7,42% | -45,02% | -51,81% | 5,28 Mrd | ||
| +0,13% | +0,76% | -0,37% | +13,20% | -2,40% | +128,11% | +188,36% | +1.449,68% | - | 4,93 Mrd | ||
| -2,53% | -6,14% | -14,02% | -18,72% | -3,63% | -6,84% | -50,53% | +82,35% | +463,64% | 4,68 Mrd | ||
| Media | -0,78% | -0,94% | -3,80% | -9,75% | -1,24% | +11,03% | +0,86% | +138,69% | +238,77% | 12,56 Mrd | |
| Media ponderata per Capi. | -1,26% | +1,03% | -1,46% | -8,61% | +0,18% | +11,36% | -4,12% | +96,29% | +294,65% |
- Borsa valori
- Azioni
- Azione HNSA
- Settore Hansa Biopharma AB
MarketScreener is also available in this country: United States.
Switch edition
Rimanere sul sito del Paese attuale